Cincinnati Children's Hospital Medical Center Dept of Oncology

Cincinnati, Ohio 45229-3039

0 studies enrolling now · 2 studies all time

What they study most

ALK-activated Tumors, Malignant Rhabdoid Tumors (MRT), Neuroblastoma

Studies at this site

• Phase I Study of LDK378 in Pediatric, Malignancies With a Genetic Alteration in Anaplastic Lymphoma Kinase (ALK) — Completed
• Study of Safety and Efficacy in Patients With Malignant Rhabdoid Tumors (MRT) and Neuroblastoma — Stopped early